211 related articles for article (PubMed ID: 15922437)
1. Secondary transitional cell carcinoma and nitrogen mustard treatment.
DeLair SM; White RW; Kurzrock EA
Urology; 2005 Jun; 65(6):1226-7. PubMed ID: 15922437
[TBL] [Abstract][Full Text] [Related]
2. [Transitional cell carcinoma of the ureter and cyclophosphamide: apropos of a case].
Ponsot Y; Guerin JG; Carmel M
Prog Urol; 1995 Sep; 5(4):578-9. PubMed ID: 7581511
[TBL] [Abstract][Full Text] [Related]
3. [Urinary bladder carcinoma was induced in a patient treated with cyclophosphamide for malignant lymphoma].
Yoshimoto K; Hisamochi A; Ogata H; Ide T; Nohno R; Fujita M; Kuboyama S; Sasaki E; Toyonaga A; Tanikawa K
Rinsho Ketsueki; 1994 Mar; 35(3):300-3. PubMed ID: 8158853
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the renal pelvis in a patient with cyclophosphamide therapy for malignant lymphoma: a case report and literature review.
Shiga Y; Suzuki K; Tsutsumi M; Ishikawa S
Hinyokika Kiyo; 2002 May; 48(5):301-5. PubMed ID: 12094715
[TBL] [Abstract][Full Text] [Related]
5. [Cyclophosphamide-induced bladder cancer: three case reports].
Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K
Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387
[TBL] [Abstract][Full Text] [Related]
6. Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
Nakamoto T; Kasaoka Y; Ikegami Y; Usui T
Hiroshima J Med Sci; 2000 Jun; 49(2):121-3. PubMed ID: 10920579
[TBL] [Abstract][Full Text] [Related]
7. [Cyclophosphamide induced urinary bladder and renal pelvic tumor--a case report].
Inagaki T; Ebisuno S
Nihon Hinyokika Gakkai Zasshi; 1998 Jul; 89(7):674-7. PubMed ID: 9739590
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
Pedersen-Bjergaard J; Ersbøll J; Hansen VL; Sørensen BL; Christoffersen K; Hou-Jensen K; Nissen NI; Knudsen JB; Hansen MM
N Engl J Med; 1988 Apr; 318(16):1028-32. PubMed ID: 3352696
[TBL] [Abstract][Full Text] [Related]
10. Bladder cancer after chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Boice JD; Fraumeni JF
N Engl J Med; 1989 Aug; 321(8):544-5. PubMed ID: 2761594
[No Abstract] [Full Text] [Related]
11. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
12. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
[TBL] [Abstract][Full Text] [Related]
13. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
14. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
[TBL] [Abstract][Full Text] [Related]
15. Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease.
Pathak AB; Advani SH; Gopal R; Nadkarni KS; Saikia TK
Leuk Lymphoma; 1992 Dec; 8(6):503-4. PubMed ID: 1297484
[TBL] [Abstract][Full Text] [Related]
16. Uracil mustard revisited.
Kennedy BJ; Torkelson JL; Torlakovic E
Cancer; 1999 May; 85(10):2265-72. PubMed ID: 10326707
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment of early cutaneous T-cell lymphoma.
Ramsay DL; Meller JA; Zackheim HS
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
[TBL] [Abstract][Full Text] [Related]
18. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
20. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
